source
- FDA acting director of cell and gene therapies Vijay Kumar to depart his postVijay Kumar, who has been serving as the acting director of the Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products, announced he will leave his position. In an inte…
- Nominations Open for 2026 Endpoints 11 Biotech AwardsNominations for the 2026 Endpoints 11 awards are now being accepted, with submissions due by July 15. The awards target private biotech startups that have differentiated science, strong leadership…